1. Selective inhibition of cell proliferation and BCR-ABL phosphorylation in acute lymphoblastic leukemia cells expressing Mr l90,000 BCR-ABL protein by a tyrosine kinase inhibitor (CGP 57148);Beran;Clin. Cancer Res.,1998
2. The current status of tyrosine kinase inhibitors;Bridges;Exp. Opin. Ther. Patents,1995
3. Inhibition of the Abl protein-tyrosine kinase in vitro and in vivo by a 2-phenylaminopyrimidine derivative;Buchdunger;Cancer Res.,1996
4. Protein-tyrosine kinase inhibitors;Burke;Drugs Future,1992
5. CGP 57148B, a tyrosine kinase inhibitor, inhibits the growth of cells expressing BCR-ABL, TEL-ABL, and TEL-PDGFR fusion proteins;Carroll;Blood,1997